| Secondary |
| Product Used For Unknown Indication |
42.6% |
| Drug Use For Unknown Indication |
19.6% |
| Suicide Attempt |
4.7% |
| Ill-defined Disorder |
4.4% |
| Intentional Overdose |
4.4% |
| Psychotic Disorder |
3.9% |
| Depression |
2.3% |
| Maternal Exposure During Pregnancy |
2.3% |
| Pulmonary Fibrosis |
2.3% |
| Bipolar Disorder |
2.1% |
| Schizoaffective Disorder |
2.1% |
| Candidiasis |
1.6% |
| Prophylaxis |
1.6% |
| Hypertension |
1.3% |
| Accidental Exposure |
1.0% |
| Chronic Obstructive Pulmonary Disease |
0.8% |
| Dementia Alzheimer's Type |
0.8% |
| Nausea |
0.8% |
| Pneumonia |
0.8% |
| Sedation |
0.8% |
|
| Suicide Attempt |
18.8% |
| Muscle Rigidity |
10.1% |
| Death |
7.2% |
| Hallucination |
5.8% |
| Somnolence |
5.8% |
| Tachyarrhythmia |
5.8% |
| Ventricular Extrasystoles |
5.8% |
| Pneumonia |
4.3% |
| Toxic Epidermal Necrolysis |
4.3% |
| Ventricular Tachycardia |
4.3% |
| Coma |
2.9% |
| Gait Disturbance |
2.9% |
| Hallucination, Visual |
2.9% |
| Hemiparesis |
2.9% |
| Hyperkalaemia |
2.9% |
| Hyponatraemia |
2.9% |
| Pleurothotonus |
2.9% |
| Syncope |
2.9% |
| Vitreous Haemorrhage |
2.9% |
| Accidental Exposure |
1.4% |
|
| Concomitant |
| Product Used For Unknown Indication |
12.7% |
| Depression |
11.7% |
| Insomnia |
6.7% |
| Conjunctivitis |
5.7% |
| Sleep Disorder |
5.7% |
| Pain |
5.3% |
| Rectal Cancer |
5.3% |
| Drug Use For Unknown Indication |
5.0% |
| Schizophrenia, Paranoid Type |
4.3% |
| Lymphangioleiomyomatosis |
4.0% |
| Non-small Cell Lung Cancer |
4.0% |
| Rash |
4.0% |
| Dementia |
3.7% |
| Restlessness |
3.7% |
| Thrombosis Prophylaxis |
3.7% |
| Atrial Fibrillation |
3.3% |
| Convulsion |
3.3% |
| Epilepsy |
2.7% |
| Micturition Disorder |
2.7% |
| Psychotic Disorder |
2.7% |
|
| Haemorrhage Intracranial |
8.8% |
| Memory Impairment |
8.8% |
| Mucosal Inflammation |
7.4% |
| Myocardial Infarction |
7.4% |
| Restlessness |
7.4% |
| Death |
5.9% |
| Muscle Atrophy |
5.9% |
| Restless Legs Syndrome |
5.9% |
| Urinary Tract Infection |
5.9% |
| General Physical Health Deterioration |
4.4% |
| Urinary Tract Infection Enterococcal |
4.4% |
| Vomiting |
4.4% |
| Affective Disorder |
2.9% |
| Agitation |
2.9% |
| Atrial Fibrillation |
2.9% |
| Depression |
2.9% |
| Encephalopathy |
2.9% |
| Injury |
2.9% |
| International Normalised Ratio Increased |
2.9% |
| Leukopenia |
2.9% |
|
| Interacting |
| Drug Use For Unknown Indication |
38.3% |
| Ill-defined Disorder |
17.0% |
| Schizophrenia |
8.5% |
| Hypertension |
6.4% |
| Product Used For Unknown Indication |
6.4% |
| Ischaemic Heart Disease Prophylaxis |
4.3% |
| Dementia |
2.1% |
| Extrapyramidal Disorder |
2.1% |
| Initial Insomnia |
2.1% |
| Prophylaxis Against Gastrointestinal Ulcer |
2.1% |
| Pruritus |
2.1% |
| Sedation |
2.1% |
| Stress Urinary Incontinence |
2.1% |
| Urinary Tract Infection |
2.1% |
| Vascular Dementia |
2.1% |
|
| Pleurothotonus |
30.0% |
| Vomiting |
30.0% |
| Grand Mal Convulsion |
15.0% |
| Akathisia |
5.0% |
| Drug Interaction |
5.0% |
| Renal Failure Acute |
5.0% |
| Sedation |
5.0% |
| Transaminases Increased |
5.0% |
|
